Creative Medical Technology Holdings, Inc. Stock Other OTC
Equities
CELZ
US22529Y2000
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 563K | Capitalization | 6.53M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -6M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 11.6 x |
P/E ratio 2024 * |
-1.03
x | P/E ratio 2025 * |
-1.28
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.33% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 16-05-17 | |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Snow
BRD | Director/Board Member | 67 | 21-12-01 |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Executive Officer | 63 | 16-05-17 |
1st Jan change | Capi. | |
---|---|---|
-2.01% | 104B | |
+1.85% | 97.42B | |
+0.79% | 22.2B | |
-17.66% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-15.61% | 15.06B | |
+4.03% | 13.98B | |
+34.88% | 11.66B |